Illness Cognitions and Coping Self-Efficacy in Depression Among Persons With Low Vision. by Sturrock, Bonnie A et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Psychiatry and Human Behavior
Faculty Papers Department of Psychiatry and Human Behavior
6-1-2016
Illness Cognitions and Coping Self-Efficacy in
Depression Among Persons With Low Vision.
Bonnie A Sturrock
University of Melbourne
Jing Xie
University of Melbourne
Edith E Holloway
University of Melbourne
Mark Hegel
Geisel School of Medicine at Dartmouth
Robin J. Casten
Thomas Jefferson University, robin.casten@jefferson.edu
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/phbfp
Part of the Ophthalmology Commons, and the Psychiatry Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Psychiatry and Human Behavior Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Sturrock, Bonnie A; Xie, Jing; Holloway, Edith E; Hegel, Mark; Casten, Robin J.; Mellor, David;
Fenwick, Eva; and Rees, Gwyneth, "Illness Cognitions and Coping Self-Efficacy in Depression
Among Persons With Low Vision." (2016). Department of Psychiatry and Human Behavior Faculty
Papers. Paper 30.
http://jdc.jefferson.edu/phbfp/30
Authors
Bonnie A Sturrock, Jing Xie, Edith E Holloway, Mark Hegel, Robin J. Casten, David Mellor, Eva Fenwick, and
Gwyneth Rees
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/phbfp/30
Low Vision
Illness Cognitions and Coping Self-Efficacy in Depression
Among Persons With Low Vision
Bonnie A. Sturrock,1 Jing Xie,1 Edith E. Holloway,1 Mark Hegel,2 Robin Casten,3 David Mellor,4
Eva Fenwick,1,5 and Gwyneth Rees1
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia
2Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States
3Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
4School of Psychology, Deakin University, Bundoora, Victoria, Australia
5Singapore Eye Research Institute (SERI), Singapore
Correspondence: Gwyneth Rees,
Behavioural Research in Ophthal-
mology, Centre for Eye Research
Australia, University of Melbourne,
Royal Victorian Eye and Ear Hospital,
Locked Bag 8, East Melbourne, Vic
8002, Australia;
grees@unimelb.edu.au.
Submitted: January 10, 2016
Accepted: April 4, 2016
Citation: Sturrock BA, Xie J, Holloway
EE, et al. Illness cognitions and coping
self-efficacy in depression among per-
sons with low vision. Invest Ophthal-
mol Vis Sci. 2016;57:3032–3038.
DOI:10.1167/iovs.16-19110
PURPOSE. To investigate the mediating role of coping self-efficacy (CSE) between two types of
illness cognitions (i.e., acceptance and helplessness) and depressive symptoms in persons
with low vision.
METHODS. This was a single-group, cross-sectional study. Patients with visual acuity < 6/12 in
the better eye and at least minimal depressive symptoms (‡5 on the Patient Health
Questionnaire-9 [PHQ-9]) were recruited from vision rehabilitation services and participated
in telephone-administered structured interviews at one time point. Measures were the PHQ-9,
CSE Scale, and Illness Cognition Questionnaire. Structural equation modeling (SEM) devised
the causal flow of illness cognitions and their observed indirect effects on depressive
symptoms via the CSE mediators: problem focused, emotion focused, and social support.
RESULTS. The study comprised 163 patients (mean age 62 years; 61% female), most with age-
related macular degeneration (26%) and moderate vision impairment (44%, <6/18–6/60).
Structural equation modeling indices indicated a perfect fit (v2 < 0.001, P ¼ 1.00),
accounting for 55% of the variance in depressive symptoms. Lower levels of acceptance and
higher levels of helplessness illness cognitions were associated with lower self-efficacy in
problem-focused coping (b ¼ 0.38, P < 0.001, b ¼ 0.28, P < 0.01, respectively), which in
turn was associated with greater depressive symptom severity (b ¼ 0.54, P < 0.001).
CONCLUSIONS. Lack of acceptance and greater helplessness relating to low vision led to a lack of
perceived capability to engage in problem-focused coping, which in turn promoted
depressive symptoms. Third-wave cognitive–behavioral treatments that focus on acceptance
may be efficacious in this population.
Keywords: illness cognitions, coping self-efficacy, low vision, depression, acceptance
Low vision (visual acuity unable to be corrected to betterthan 6/12 in the better eye1) can lead to significant vision-
specific and/or psychological distress.2–4 For example, research
suggests that more than 30% of individuals with low vision have
subthreshold depressive symptoms4,5 and that, for older people
with low vision, the prevalence of depression is at least double
that of matched samples of those without low vision.4,6
However, the impact of low vision on emotional well-being
varies greatly from person to person, even among those with
comparable eye diagnoses.7 Furthermore, severity of vision
impairment incompletely explains the detrimental effect of
ophthalmologic disease on emotional well-being and function-
ing.8,9 Thus, the psychological outcomes of low vision are most
likely, at least in part, determined by intrapersonal factors.3,10,11
Two such factors are illness cognitions and coping self-efficacy
(CSE).
Illness cognitions occur in response to chronic disease/
disability when an individual has evaluated how much his or
her condition could impede daily and goal-directed ac-
tions.10,12,13 The two overarching types of illness cognitions
are helplessness and acceptance. Helplessness illness cogni-
tions involve preoccupation with the adverse effects of low
vision, its permanence, and unmanageability with regard to day-
to-day functioning.13,14 In contrast, acceptance illness cogni-
tions entail acknowledgement of low vision and confidence in
living with and adapting to the limitations.13 Previous research
has shown that illness cognitions play an important role in
protecting against or promoting depressive symptoms in the
context of chronic conditions other than low vision.7 Evidence
suggests that greater acceptance of vision impairment is
associated with improved psychological adjustment3,7,11,15
and, in other chronic health conditions, poorer psychological
outcomes have been related to increased helplessness.7,13,14
Coping self-efficacy, one’s perceived capability to use coping
strategies to deal with health-related disturbances,16 may also
account for variability in the impact of low vision on
psychological outcomes. Maladaptive coping, particularly
avoidant coping, has been found to reduce vision-related
quality of life over time,9 while adaptive coping, specifically
instrumental coping, social support, and use of assistive aids,
predicts better adjustment to vision impairment.11 While
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studies have explored actual coping behavior among people
with low vision, CSE is yet to be investigated in this population.
As a whole, part of the variation in psychological outcomes
for individuals with low vision may arise both from illness
cognitions and perceived capability for adaptive coping.
Because CSE and actual coping occur after a problem is
identified (i.e., low vision) and considered, we propose that
the relationship between illness cognitions and depression will
be mediated by CSE. For example, greater acceptance may lead
to greater adaptive CSE in making a plan of action to improve
mobility, engaging in meditation, and/or obtaining assistance
from others, which then serve to protect against depressive
symptoms. Henceforth, our aim was to test the assertion that
illness cognitions contribute to depressive symptoms via CSE
in a low vision population. We hypothesized that greater
helplessness and lower acceptance would be associated with
increasing depressive symptoms, and that adaptive CSE (i.e.,
problem-focused coping, emotion- and cognitive-focused cop-
ing, and/or seeking social support) would mediate the
relationship between illness cognitions and depressive symp-
toms.
MATERIALS AND METHODS
Participants and Recruitment
Participants were recruited across Australia from Vision
Australia, a low vision rehabilitation service provider. Partici-
pants who met screening criteria for age (‡18 years) and
scored ‡3 on the Patient Health Questionnaire-2 (PHQ-2)17
were identified by Vision Australia staff. Eligible participants (N
¼ 529) were then contacted by researchers to assess additional
eligibility criteria and invited to complete the telephone-
administered structured interview with a trained research
assistant/PhD level student. At this juncture, participants
required a score of ‡5 on the PHQ-9 (PHQ-9),18,19 best-
corrected visual acuity <6/12 in the better eye, the ability to
converse in English, adequate hearing using a hearing aid if
necessary, no active treatment for a mental health condition,
independent living in the community, and no cognitive
impairment as determined by the 6-item Cognitive Impairment
Test (CIT6).20
Informed written consent was obtained from all partici-
pants via mail. Ethical approval was provided by Human
Research and Ethics Committees of the Royal Victoria Eye and
Ear Hospital (12/1061H) and Deakin University (2012-139).
This research adhered to the tenets of the Declaration of
Helsinki.
Design
A single-group, cross-sectional design was used. Our study
reports on baseline data collected between the years 2012 and
2015 from 163 patients with low vision and depressive
symptomatology who were enrolled in a two-arm randomized
controlled trial (RCT) that aimed to explore the effectiveness of
problem-solving therapy for primary care (PST-PC) in reducing
depressive symptoms. Details of the RCT are described
elsewhere21 (ACTRN12612000318886).
Demographics
Participants’ data on age, eye diseases, self-reported general
health, and marital, educational, and residential statuses were
collected. Vision Australia records provided most recent
Snellen assessed visual acuity, categorized into mild, <6/12
to 6/18; moderate, <6/18 to 6/60; and severe, <6/60 vision
impairment.
Depressive Symptom Severity
The PHQ-918,19 assesses the frequency with which participants
experienced nine symptoms over the past 2 weeks. They were
asked, for example, ‘‘Over the last 2 weeks, how often have
you been bothered by . . . feeling down, depressed, or
hopeless’’? Responses were rated on a four-point Likert scale
ranging from ‘‘not at all’’¼ 0 to ‘‘nearly every day’’¼ 3, with a
summed score range of 0 to 27. Higher scores indicate
increasing depressive symptoms, and a score of ‡10 is the
threshold for clinical levels of depression, with a sensitivity and
specificity of 88% in detecting major depressive disorder.18 The
PHQ-9 has been validated for use with patients with vision
impairment22 and administration over the telephone.23
Intrapersonal Psychological Factors
The Illness Cognition Questionnaire (ICQ)13 is chiefly used
with patients with multiple sclerosis, chronic pain, or
rheumatoid arthritis, but can be adapted to the specific
condition in question. The ICQ is made up of 18 items,
measuring three ways people assign meaning to their chronic
disease: (1) ‘‘Acceptance’’ (six items), reflecting acknowledge-
ment of one’s low vision and perceived ability to positively
manage its negative consequences—for example, ‘‘I have
learned to live with my vision impairment’’; (2) ‘‘Helplessness’’
(six items) focusing on the negative consequences of low
vision and overgeneralizing these to functioning in daily life—
for example, ‘‘My vision impairment limits me in everything
that is important to me’’; and (3) ‘‘Perceived benefits’’ (six
items) exploring any benefits a person may experience as a
result of their vision impairment—for example, ‘‘My vision
impairment has taught me to enjoy the moment more.’’ The
latter scale was not included in our study as we did not form
any specific hypotheses about the impact of perceived benefits
of low vision on depressive symptoms; this was based on the
lack of theoretical and empirical standing of this variable with
regard to the variables of interest and in our specified
population. The four-point Likert scale ranges from ‘‘not at
all’’ ¼ 1 to ‘‘completely agree’’ ¼ 4. Summed increasing scale
scores indicate that acceptance and helplessness with regard
to low vision are held to a larger degree by the respondent. The
ICQ has demonstrated strong internal reliability, as well as
good construct and predictive validity across chronic condi-
tions,13 and has previously been used over the telephone in a
low vision population.24
The Coping Self-Efficacy Scale (CSE)25 consists of 26 items
assessing confidence in one’s ability to cope effectively with
life challenges. The three subscales are: (1) ‘‘Problem-
Focused’’—for example, ‘‘Make a plan of action and follow it
when confronted with a problem’’ (12 items); (2) ‘‘Stop
Unpleasant Emotions/Thoughts’’—for example, ‘‘Look for
something good in a negative situation’’ (9 items); and (3)
‘‘Support from Friends/Family’’—for example, ‘‘Get emotional
support from friends and family’’ (5 items). The preceding
statement for each item was ‘‘When things aren’t going well for
you, or when you’re having problems, how confident or
certain are you that you can do the following . . . ?’’ On an 11-
point anchored scale for each item, participants indicated the
extent to which they could perform in accordance with the
coping statement. Anchor points were ‘‘cannot do at all’’¼0 to
‘‘moderately certain can do’’ ¼ 5 and ‘‘certainly can do’’ ¼ 10,
with a higher score indicating greater CSE. The CSE has
demonstrated excellent internal reliability and concurrent and
predictive validity,25 and has been successfully used in auditory
format.26
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Psychometric Assessment of the Measures
Rasch analysis was used to assess the psychometric properties
of all scales and to derive interval measures for analysis. The
Andrich rating scale model27 was used with Winsteps software
(version 3.75; Chicago, IL, USA).28 Rasch analysis is a form of
item response theory in which the ordinal ratings of the
questionnaire are transformed to estimates of interval measures
(expressed in log of the odd units, or logits). Rasch analysis
provides significant insight into the psychometric properties of
the scale, including appropriate use of response categories,
measurement precision, how well items fit the underlying trait,
unidimensionality, targeting of item difficulty to patients’
ability, and differential item functioning (DIF). Rasch analysis
is important for studies using rating scales, as loss of
measurement quality due to participants’ poor understanding
of questions or underutilization of response categories can
reduce the value of clinical research.29–31
The PHQ-9 demonstrated acceptable fit to Rasch model
parameters, although precision fell just below acceptable
levels, suggesting that there was a lack of variance across the
spectrum of depression in the sample. The ICQ Acceptance
and Helplessness subscales demonstrated excellent fit to the
Rasch model, with good precision and targeting, and no
evidence of multidimensionality or item misfit. The Problem-
Focused subscale of the CSE had disordered thresholds that
were resolved by collapsing response categories from 10 to 6.
Item 9, ‘‘Talk positively to yourself,’’ displayed substantial
misfit and was therefore removed. The Stop Unpleasant
Emotions/Thoughts subscale of the CSE also required catego-
ries to be collapsed from 10 to 7 to resolve disordered
thresholds. There was some evidence of multidimensionality
and minor item misfit. Finally, the Support from Family/Friends
subscale required categories to be collapsed from 10 to 6 to
resolve disordered thresholds, and item 2, ‘‘Get emotional
support from friends and family,’’ displayed minor misfit. For all
measures, the derived logit scores were transformed to a 0 to
10 scale to assist in interpretation. A higher score indicates that
a person possesses a high level of the assessed latent trait (e.g.,
helplessness, acceptance, depressive symptoms, and CSE).
Statistical Analysis
Descriptive analyses were performed on all variables. Continu-
ous variables are presented as mean and standard deviation (SD)
for the normally distributed data, whereas categorical variables
are presented as absolute (n) and relative frequencies (%).
Pearson’s correlation analyses were used to establish associa-
tions between the variables of interest, followed by mediation
analysis32 to evaluate the hypothesis that CSE mediates the
relationship between illness cognitions and depressive symp-
toms. To interpret the mediational results, a structural equation
model (SEM) was devised to encapsulate the causal flow of
illness cognitions and their observed indirect effects on
depressive symptoms via the multiple CSE mediating variables:
problem focused, emotion focused, and social support. Struc-
tural equation modeling permits exploration of total, direct, and
indirect effects among the variables of interest. Bootstrapping
analysis with 5000 bootstraps was used; this is the current
preferred method for testing indirect effects.33 Bootstrapping is
a nonparametric resampling method that generates an estimate
of the indirect effect, and it does not require assumptions about
the shape of the sampling distribution that underlie the Sobel
test. The data met all of the assumptions for SEM, and shared
variance and muticollinearity were not problematic in this
sample. Age and self-reported health status were included as
control variables, as these were the only covariates significant in
the univariate regression analyses; severity of vision impairment
was not adjusted in the model, as it was not associated with
PHQ-9 depression scores (P¼ 0.204). To evaluate overall model
fit, several fit indices were used: the v2 goodness-of-fit statistic,
the Tucker-Lewis index (TLI), the Bentler comparative fit index
(CFI), and the root mean square error of approximation
(RMSEA). A model is considered to have good fit if the v2
statistic is nonsignificant, TLI and CFI are greater than 0.95,34
and the RMSEA is below 0.05.35 The data were analyzed through
SEM with maximum likelihood estimation using Stata 14.1
(StataCorp, College Station, TX, USA). All statistical tests were 2-
sided with a 0.05 level of significance.
RESULTS
Of the 529 persons who had a telephone assessment, 200
declined to participate (Table 1; people who declined were
significantly older than those who participated in the study [P <
0.001]); 88 did not meet inclusion criteria (i.e., currently
engaged in psychological treatment [n ¼ 26], hearing was
inadequate [n ¼ 17], cognitively impaired [n ¼ 16], not living
independently [n ¼ 12], PHQ-9 score of <5 [n ¼ 8], and non-
English speaking [n¼9]); 76 were unable to be contacted, and 2
were deceased. The final sample consisted of 163 participants.
Participant Characteristics
The sample (Table 2) of 163 participants included 99 women
(mean age¼65.0 years, SD¼15.9 years) and 64 men (mean age
¼ 58.4 years, SD ¼ 17.6 years). Twenty-nine percent of
participants had mild (n ¼ 48; <6/12–6/18), 44% moderate
(n¼ 72; <6/18–6/60), and 26% severe vision impairment (n¼
43; <6/60). The mean duration of low vision was 15.6 years
(SD ¼ 18.5). Age-related macular degeneration was the most
frequently diagnosed primary eye condition (26%, n¼43); 14%
(n ¼ 23) were diagnosed with diabetic retinopathy; 12% (n ¼
20) had optic nerve damage; and 48% (n¼78) had other vision
conditions (e.g., nystagmus).
TABLE 1. Differences Between Participants in the Study and Those Who Declined to Participate
Characteristics Participants in the Study, N ¼ 163 People Who Declined to Participate, N ¼ 200 P Value
Age, y, mean (SD) 62.4 (16.9) 78.3 (17.4) <0.001
Sex, male, n (%) 64 (39.3) 62 (31.0) 0.100
Vision impairment, n (%)
Mild VI 48 (29.4) 48 (24.0) 0.344
Moderate VI 72 (44.2) 103 (51.5)
Severe 43 (26.4) 49 (24.5)
VI/blindness
Comorbid eye diseases (yes) 29 (17.8) 24 (12.6) 0.170
Bold number indicates significant P values. VI, vision impairment.
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Univariate and Multivariate Analysis
Pearson correlation coefficients (Table 3) showed that depres-
sion scores were associated with the predictor variables as
expected; a moderate positive relationship was observed
between PHQ-9 Depression and ICQ Helplessness, and
moderate negative relationships were found between PHQ-9
Depression and ICQ Acceptance and all of the CSE subscales.
Illness Cognition Questionnaire Helplessness and Acceptance
had a strong negative relationship with each other, and both
were moderately correlated with the CSE subscales. Illness
Cognition Questionnaire Helplessness was negatively associat-
ed with the CSE subscales, whereas ICQ Acceptance was
positively associated with the CSE subscales.
Mediation analysis (Table 4) showed that the previous
significant relationships between the ICQ subscales and PHQ-9
Depression became nonsignificant after the introduction of the
mediators (i.e., CSE subscales). Only CSE Problem-Focused
added a substantial amount of variance to the model and
served as a mediator between the ICQ subscales and PHQ-9
(i.e., ICQ Acceptance and Helplessness had no significant
effect on PHQ-9 Depression when CSE Problem-Focused was
introduced).32
The standardized parameter estimates for the SEM analysis
can be viewed in the Figure. The final model fit indices
indicated a perfect fit, and the data accounted for 55% of the
variance in PHQ-9 Depression. v2 was <0.001, P ¼ 1.00; CFI
was 1.00; TLI was 1.0; standardized root mean squared residual
(SRMR) was <0.001; standardized root mean residual was
<0.001; RMSEA was <0.001, with a 90% confidence level of
0.000 to 0.000 (all of the statistics were well within range). As
displayed in the Figure, a negative direct effect was found, such
that lower CSE Problem-Focused was associated with increas-
ing PHQ-9 Depression scores (b¼0.54, P < 0.001). As shown
in Table 5, a negative indirect effect was found between ICQ
Acceptance and PHQ-9 Depression scores via CSE Problem-
Focused (b ¼0.16, SE ¼ 0.05, P ¼ 0.001). A positive indirect
effect was found between ICQ Helplessness and PHQ-9
Depression scores via CSE Problem-Focused (b ¼ 0.13, SE ¼
0.05, P ¼ 0.009). Thus, lower levels of acceptance predict
greater depressive symptoms via lower levels of problem-
focused CSE, while higher levels of helplessness predict greater
depressive symptoms via lower levels of problem-focused CSE.
The total effects of ICQ Acceptance and Helplessness on PHQ-
9 Depression scores were0.25 (SE¼0.08, P¼0.001) and 0.24
(SE ¼ 0.09, P ¼ 0.010), respectively. Direct effects were also
found for ICQ Helplessness and CSE Social Support (b¼0.27,
SE ¼ 0.11, P ¼ 0.011), ICQ Acceptance and CSE Emotions/
Thoughts (b¼0.42, SE¼0.09, P < 0.001), and ICQ Acceptance
and CSE Social Support (b ¼ 0.27, SE ¼ 0.11, P ¼ 0.011).
DISCUSSION
Our novel study provides evidence for the role of illness
cognitions and problem-focused CSE in depressive symptoms
among persons with low vision. Independent of age and self-
reported health status, how one thinks about one’s low vision
and one’s perceived ability to use problem-focused coping
accounted for a considerable proportion of the variance in
depressive symptoms. Specifically, greater levels of depressive
symptoms were predicted by lower levels of problem-focused
CSE, which, in turn, was determined by lower levels of
acceptance and greater levels of helplessness.
The findings support the view that illness cognitions are an
important factor linking disease to psychological well-being
generally12,13,36 and vision impairment specifically. In support
of our hypotheses, both acceptance and helplessness illness
cognitions were associated with depression in the manner
predicted. This is consistent with previous studies linking
improved psychological adjustment to acceptance of vision
impairment,3,7,11,15 and poorer psychological outcomes in
chronic health conditions to increased helplessness.7,13,14
When the role of CSE was investigated, only partial support
for our mediational hypothesis was obtained; problem-focused
CSE mediated the relationships between the illness cognitions
and depression. However, in the path model, helplessness
illness cognitions predicted both lower social support and
TABLE 2. Sociodemographic and Psychosocial Participant Characteris-
tics at Baseline Participant Characteristics (n¼ 163)
Categorical variables
Sex
n (%)
Female 99 (60.7)
Male 64 (39.3)
Marital status
Single/widowed/never married 93 (57.1)
Married/de facto 70 (42.9)
Health status
Excellent 12 (7.3)
Good 28 (17.1)
Very good 52 (31.7)
Fair 39 (23.8)
Poor 33 (20.1)
Education level
None/primary school 12 (7.4)
Some secondary/technical 95 (58.3)
Secondary completed 17 (10.4)
Trade/apprenticeship/TAFE 12 (7.3)
University 27 (16.6)
Residing with someone
No 54 (33.1)
Yes 109 (66.9)
Visual impairment
Mild 48 (29.4)
Moderate 72 (44.2)
Severe/blindness 43 (26.4)
Comorbid eye diseases
No 29 (17.8)
Yes 134 (82.2)
Continuous variables Mean (SD)
Age, y 62.4 (16.9)
Rasched ICQ Helplessness 5.04 (2.28)
Rasched ICQ Acceptance 4.76 (2.44)
Rasched CSE Emotions/Thoughts 4.03 (1.82)
Rasched CSE Problem-Focused 4.71 (1.91)
Rasched CSE Social Support 5.51 (1.73)
Rasched PHQ-9 Depression 3.22 (1.91)
TAFE, technical and further education.
TABLE 3. Correlations Between Illness Cognitions, CSE, and Depres-
sive Symptoms (n ¼ 163)
Variable 1 2 3 4 5 6
1. ICQ Helplessness – 0.75 0.55 0.59 0.48 0.57
2. ICQ Acceptance – 0.59 0.60 0.50 0.55
3. CSE Emotions/Thoughts – 0.77 0.58 0.60
4. CSE Problem-Focused – 0.64 0.71
5. CSE Social Support – 0.48
6. PHQ-9 Depression –
Higher subscale scores indicate a greater degree of illness
cognitions and CSE.
All values are P < 0.001.
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problem-focused CSE, while acceptance illness cognitions
predicted higher CSE for all domains. This demonstrates that
helplessness and acceptance impact various aspects of CSE; yet
CSE in social support and stopping unpleasant emotions and
thoughts did not serve as significant mediators of depression.
The findings suggest that acceptance illness cognitions may be
a necessary prerequisite for all domains of CSE that were
explored. Adaptive emotion regulation, strategies to deal with
unhelpful thoughts, and seeking appropriate social support are
well-known protective factors for mental health, and the
findings reflect the significant impact of illness cognitions on
these domains. In contrast, helplessness illness cognitions are
associated with withdrawal from others and not seeking
appropriate support out of fear, shame, or embarrassment
regarding vision loss. Thus, intervening with how one
interprets one’s illness and manages unhelpful cognitions or
uncomfortable emotions is the first step to build CSE to protect
against or treat depression in persons with low vision.
Importantly, how people think about chronic illness and
how they evaluate their ability to cope with it are modifiable.
Illness cognitions and problem-focused CSE provide concrete
starting points for designing targeted interventions to modify
or neutralize unhelpful cognitions. Cognitive–behavioral treat-
ments, problem-solving treatment (PST), or acceptance and
commitment therapy (ACT) is likely to be efficacious in
protecting against and reducing depressive symptoms among
individuals with low vision. However, PST may be most
effective for those individuals who have greater levels of
acceptance in relation to their vision impairment.9 Acceptance
and commitment therapy, on the other hand, focuses on
building acceptance by helping people to create a ‘‘rich, full,
and meaningful life while accepting the pain that life inevitably
brings’’ (p. 2).37 Through neutralizing or defusing helplessness-
related cognitions, building acceptance, and designing values-
driven goal-directed behavior acting to increase problem-
focused CSE, the client is gradually activated in a behavioral
sense and begins to achieve personal goals. While there is vast
evidence for the efficacy of ACT in the treatment of depression,
ACT in low vision has not yet been tested.
Our study is the first to explore a mediational path model
elucidating the effect of illness cognitions on CSE and
depressive symptoms in low vision. Strengths of the study
include the use of Rasch analysis to validate outcome measures
and transform ordinal scores to interval-level measurement,
and sophisticated SEM provides assurance regarding the
robustness of our model. However, there are also a number
of shortcomings. First, as the sample was engaged with low
vision rehabilitation services and agreed to take part in an RCT
for depression management and thus was treatment seeking,
the findings may not be extrapolated to the broader population
of low vision patients who do not seek support. As a result, the
findings may be understated as patients were engaged in
rehabilitation programs that promote well-being. Second,
while there was a proportion of patients (37.8%) who declined
to participate in our study, the refusal rate is not unlike what is
seen in other studies conducting health research, with refusal
rates reported as high as 53%.38 In fact, across all epidemio-
logic study designs, there has been an observed decrease in
participation due to nonresponse and refusal over time.39
Nonetheless, the nonparticipation rate observed in our study
may impact the generalizability of the findings and may have
resulted in reduced statistical power suggesting that our
findings could further be understated. Third, we observed
that persons who declined to participate in the study were
significantly older than those who agreed to participate. Our
findings suggest that willingness to engage in health research
decreases with increasing age. This finding is not consistent
with other research exploring factors that affect willingness to
participate in studies,38 but could be indicative of a range of
factors including the positive relationship between increasing
depressive symptoms and age found in patients with vision
impairment.4,40 In other words, patient refusal may be related
to low motivation, fatigue, and other symptoms of depression
that are also further intensified by increasing age. While we did
not gather data on depressive symptoms in nonparticipants,
this finding could again indicate that our results are understat-
ed and may impact the findings’ generalizability. Fourth,
additional psychosocial influences that could predispose
people to unhelpful cognitions, such as a biological vulnera-
bility to depression or personality traits (e.g., neuroticism),
were not explored. It could also be argued that exploring
illness cognitions in a sample of individuals who have an
increased prevalence of depressive symptoms may be prob-
lematic because mood state may impact cognitions, implying
reverse causality.41 Finally, the issues with fit to the Rasch
model for some measures mean that the results must be
interpreted with some caution.
TABLE 4. Univariate and Multivariate Linear Regression Models for the Mediational Effect of CSE Between Illness Cognitions and Depressive
Symptoms
Variable
Univariate Linear Regression Multivariate Linear Regression*
b (95% CI) b (95% CI)
1. ICQ Helplessness 0.48 (0.36, 0.61)† 0.11 (0.05, 0.27)
2. ICQ Acceptance 0.41 (0.50, 0.32)† 0.09 (0.22, 0.03)
3. CSE Emotions/Thoughts 0.63 (0.77, 0.50)† 0.03 (0.20, 0.14)
4. CSE Problem-Focused 0.68 (0.80, 0.56)† 0.53 (0.73, 0.34)†
5. CSE Social Support 0.51 (0.64, 0.39)† 0.01 (0.16, 0.18)
CI, confidence interval.
* Model included the variables significant in the univariate regression analyses: age and self-reported health status.
† P < 0.001.
FIGURE. Path diagram of the model tested to evaluate the impact of
illness cognitions and CSE on depressive symptoms. Higher scores
indicate a greater degree of illness cognitions and CSE. *P < 0.05, **P <
0.01, ***P < 0.001.
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Future research could confirm our findings using a
longitudinal design, as the factors explored in this study are
dynamic (i.e., cognitive factors, visual acuity, depressive
symptoms). Other studies could explore, using a three-armed
RCT, the effectiveness of PST versus ACT versus control in a
low vision population to enhance positive intrapersonal factors
and improve mental health outcomes; this would help to
determine the mechanisms of change in the tested psycholog-
ical interventions. Researchers may also want to trial depres-
sion treatment interventions before providing vision
rehabilitation services to examine if the uptake and outcomes
of those rehabilitation services improve. Additional studies
could explore whether the model tested in this study fits with
other mental health problems (e.g., anxiety) in low vision and
assess for predisposing biopsychosocial factors. Studies may
also include participants with vision impairment from the
general population who are not actively engaged in vision
rehabilitation programs.
In conclusion, our novel findings suggest that problem-
focused CSE mediates the relationship between helplessness
and acceptance illness cognitions on the one hand and
depressive symptoms on the other. Psychological interventions
that promote adaptive and reduce maladaptive illness cogni-
tions and increase problem-focused CSE may be successful in
reducing depressive symptoms in people with low vision.
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